A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)

Clinical trial NCT07742735 · RECRUITING

Trial details

NCT number: NCT07742735
Sponsor: VectivBio AG
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Short Bowel Syndrome (SBS)SBS Associated With Intestinal Failure (SBS-IF)

Start date: 2026-08-01
Primary completion: 2028-10-01
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.